Honz Pharmaceutical Co., Ltd. (SHE:300086)
9.57
+0.15 (1.59%)
Feb 4, 2026, 3:05 PM CST
Honz Pharmaceutical Company Description
Honz Pharmaceutical Co., Ltd. engages in the research and development, manufacturing, and sales of pediatric medicines in China.
The company offers medicines for children and adults in the areas of anti-anaphylaxis, antidiarrheal and digestive, relieving cough, anti-flu, antipyretic, anti-infection, anti-fungal, antipyretic-analgesic, and endocrine; and medical, disposable, and protective face masks.
It markets its products through a network of agents and sales terminals. Honz Pharmaceutical Co., Ltd. was formerly known as HaiNan Honz Pharmaceutical Co.,Ltd. and changed its name to Honz Pharmaceutical Co., Ltd. in November 2016.
Honz Pharmaceutical Co., Ltd. was founded in 1993 and is based in Guangzhou, China.
Honz Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1993 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 659 |
| CEO | Jiangyou Hong |
Contact Details
Address: Dongshan Square Guangzhou China | |
| Phone | 86 20 8732 4060 |
| Website | honz.com.cn |
Stock Details
| Ticker Symbol | 300086 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000QM6 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Liping Hong | Vice Chairman and Vice President |
| Dexin Lin | Vice President and Board Secretary |
| Yong Wang | Assistant to the Chairman |
| Jiangyou Hong | Chairman and President |
| Jing Li | Chief Financial Officer and Accounting Supervisor |